Cargando…
Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
The aim of this study was to examine the anti-inflammatory effect of abciximab-coated stent in a porcine coronary overstretch restenosis model. Ten abciximab-coated stents, ten sirolimus-eluting stents (SES), and ten paclitaxel-eluting stents (PES) were deployed with oversizing (stent/artery ratio 1...
Autores principales: | Hong, Young Joon, Jeong, Myung Ho, Lee, Sang Rok, Hong, Seo Na, Kim, Kye Hun, Park, Hyung Wook, Kim, Ju Han, Kim, Weon, Ahn, Youngkeun, Cho, Jeong Gwan, Park, Jong Chun, Kang, Jung Chaee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693844/ https://www.ncbi.nlm.nih.gov/pubmed/17982226 http://dx.doi.org/10.3346/jkms.2007.22.5.802 |
Ejemplares similares
-
Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2011) -
Effects of Ramiprilat-Coated Stents on Neointimal Hyperplasia, Inflammation, and Arterial Healing in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2011) -
Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model
por: Jang, Suyoung, et al.
Publicado: (2017) -
The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease
por: Kim, Weon, et al.
Publicado: (2004) -
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)